Skip to content
Boost Up Blog – Lifestyle
Author:
Silexion Therapeutics Corp
Columbus McKinnon Delivers Order Growth of 20% and Net Sales Growth of 24% in FY26; Issues FY27 Guidance
June 4, 2026
Silexion Therapeutics Announces 1-for-10 Reverse Share Split
May 26, 2026
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 21, 2026
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May 21, 2026
Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
May 21, 2026
←
Previous Page
1
2